Anandamide

Anandamide is a lipid of Fatty Acyls (FA) class. Anandamide is associated with abnormalities such as Dehydration. The involved functions are known as Process, Phenomenon, Phosphorylation, Catabolic Process and Gene Expression. Anandamide often locates in Nuchal region, Microglial and Hepatic. The associated genes with Anandamide are SGPL1 gene, SPTLC1 gene, RPSA gene, KDSR gene and SMPD1 gene. The related lipids are Sphingolipids, Lipopolysaccharides, Lysophospholipids, LYSO-PC and lysophosphatidylethanolamine.

Cross Reference

Introduction

To understand associated biological information of Anandamide, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Anandamide?

Anandamide is suspected in Dehydration and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Anandamide

MeSH term MeSH ID Detail
Ventricular Fibrillation D014693 16 associated lipids
Fever D005334 35 associated lipids
Bronchial Spasm D001986 18 associated lipids
Morphine Dependence D009021 9 associated lipids
Shock, Septic D012772 11 associated lipids
Cough D003371 19 associated lipids
Encephalomyelitis, Autoimmune, Experimental D004681 26 associated lipids
Catalepsy D002375 30 associated lipids
Migraine Disorders D008881 11 associated lipids
Cardiomyopathy, Dilated D002311 15 associated lipids
Per page 10 20 50 100 | Total 105

PubChem Associated disorders and diseases

What pathways are associated with Anandamide

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Anandamide?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Anandamide?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Anandamide?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Anandamide?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Anandamide?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Anandamide

Download all related citations
Per page 10 20 50 100 | Total 2222
Authors Title Published Journal PubMed Link
del Carmen García M et al. Hypotensive effect of anandamide through the activation of CB1 and VR1 spinal receptors in urethane-anesthetized rats. 2003 Naunyn Schmiedebergs Arch. Pharmacol. pmid:14504685
Barinaga M Pot, heroin unlock new areas for neuroscience. 1992 Science pmid:1335165
Hillard CJ and Jarrahian A Cellular accumulation of anandamide: consensus and controversy. 2003 Br. J. Pharmacol. pmid:12970089
Segall Y et al. Arachidonylsulfonyl derivatives as cannabinoid CB1 receptor and fatty acid amide hydrolase inhibitors. 2003 Bioorg. Med. Chem. Lett. pmid:12951114
Liu J et al. Lipopolysaccharide induces anandamide synthesis in macrophages via CD14/MAPK/phosphoinositide 3-kinase/NF-kappaB independently of platelet-activating factor. 2003 J. Biol. Chem. pmid:12949078
Fowler CJ et al. Inhibition of C6 glioma cell proliferation by anandamide, 1-arachidonoylglycerol, and by a water soluble phosphate ester of anandamide: variability in response and involvement of arachidonic acid. 2003 Biochem. Pharmacol. pmid:12948856
Franklin A et al. Palmitoylethanolamide increases after focal cerebral ischemia and potentiates microglial cell motility. 2003 J. Neurosci. pmid:12944505
Helyes Z et al. Inhibitory effect of anandamide on resiniferatoxin-induced sensory neuropeptide release in vivo and neuropathic hyperalgesia in the rat. 2003 Life Sci. pmid:12941436
Cravatt BF and Lichtman AH Fatty acid amide hydrolase: an emerging therapeutic target in the endocannabinoid system. 2003 Curr Opin Chem Biol pmid:12941421
Maccarrone M and Finazzi-Agró A The endocannabinoid system, anandamide and the regulation of mammalian cell apoptosis. 2003 Cell Death Differ. pmid:12934069
Fasia L et al. Uptake and metabolism of [3H]anandamide by rabbit platelets. Lack of transporter? 2003 Eur. J. Biochem. pmid:12919314
Dogulu FH et al. Intra-arterial simultaneous administration of anandamide attenuates endothelin-1 induced vasospasm in rabbit basilar arteries. 2003 Acta Neurochir (Wien) pmid:12910401
Storr M et al. Cannabinoid receptor type 1 modulates excitatory and inhibitory neurotransmission in mouse colon. 2004 Am. J. Physiol. Gastrointest. Liver Physiol. pmid:12893627
Kozak KR et al. Amino acid determinants in cyclooxygenase-2 oxygenation of the endocannabinoid anandamide. 2003 Biochemistry pmid:12885237
Watanabe H et al. Anandamide and arachidonic acid use epoxyeicosatrienoic acids to activate TRPV4 channels. 2003 Nature pmid:12879072
Sokal DM et al. Intraplantar injection of anandamide inhibits mechanically-evoked responses of spinal neurones via activation of CB2 receptors in anaesthetised rats. 2003 Neuropharmacology pmid:12871657
Sarker KP and Maruyama I Anandamide induces cell death independently of cannabinoid receptors or vanilloid receptor 1: possible involvement of lipid rafts. 2003 Cell. Mol. Life Sci. pmid:12861385
González S et al. Region-dependent changes in endocannabinoid transmission in the brain of morphine-dependent rats. 2003 Addict Biol pmid:12850774
Patel S et al. The general anesthetic propofol increases brain N-arachidonylethanolamine (anandamide) content and inhibits fatty acid amide hydrolase. 2003 Br. J. Pharmacol. pmid:12839875
Bojesen IN and Hansen HS Binding of anandamide to bovine serum albumin. 2003 J. Lipid Res. pmid:12837852
Nicholson RA et al. Sodium channel inhibition by anandamide and synthetic cannabimimetics in brain. 2003 Brain Res. pmid:12834914
Obata T et al. Simultaneous determination of endocannabinoids (arachidonylethanolamide and 2-arachidonylglycerol) and isoprostane (8-epiprostaglandin F2alpha) by gas chromatography-mass spectrometry-selected ion monitoring for medical samples. 2003 J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. pmid:12829006
Ahluwalia J et al. Anandamide regulates neuropeptide release from capsaicin-sensitive primary sensory neurons by activating both the cannabinoid 1 receptor and the vanilloid receptor 1 in vitro. 2003 Eur. J. Neurosci. pmid:12823468
Maccarrone M et al. The endocannabinoid system in human keratinocytes. Evidence that anandamide inhibits epidermal differentiation through CB1 receptor-dependent inhibition of protein kinase C, activation protein-1, and transglutaminase. 2003 J. Biol. Chem. pmid:12815050
Wilson SJ et al. A high-throughput-compatible assay for determining the activity of fatty acid amide hydrolase. 2003 Anal. Biochem. pmid:12814631
Klegeris A et al. Reduction of human monocytic cell neurotoxicity and cytokine secretion by ligands of the cannabinoid-type CB2 receptor. 2003 Br. J. Pharmacol. pmid:12813001
Shiraishi T et al. The presence of ceramidase activity in liver nuclear membrane. 2003 Biol. Pharm. Bull. pmid:12808285
Patel S et al. Differential regulation of the endocannabinoids anandamide and 2-arachidonylglycerol within the limbic forebrain by dopamine receptor activity. 2003 J. Pharmacol. Exp. Ther. pmid:12808005
Han J et al. Properties and modulation of the G protein-coupled K+ channel in rat cerebellar granule neurons: ATP versus phosphatidylinositol 4,5-bisphosphate. 2003 J. Physiol. (Lond.) pmid:12807991
Maccarrone M et al. Progesterone activates fatty acid amide hydrolase (FAAH) promoter in human T lymphocytes through the transcription factor Ikaros. Evidence for a synergistic effect of leptin. 2003 J. Biol. Chem. pmid:12799380
El Fangour S et al. Hemisynthesis and preliminary evaluation of novel endocannabinoid analogues. 2003 Bioorg. Med. Chem. Lett. pmid:12781177
Vásquez C et al. Effects of cannabinoids on endogenous K+ and Ca2+ currents in HEK293 cells. 2003 Can. J. Physiol. Pharmacol. pmid:12774849
Tarzia G et al. Design, synthesis, and structure-activity relationships of alkylcarbamic acid aryl esters, a new class of fatty acid amide hydrolase inhibitors. 2003 J. Med. Chem. pmid:12773040
Oz M et al. The endogenous cannabinoid anandamide inhibits alpha7 nicotinic acetylcholine receptor-mediated responses in Xenopus oocytes. 2003 J. Pharmacol. Exp. Ther. pmid:12766252
Veldhuis WB et al. Neuroprotection by the endogenous cannabinoid anandamide and arvanil against in vivo excitotoxicity in the rat: role of vanilloid receptors and lipoxygenases. 2003 J. Neurosci. pmid:12764100
Ahern GP Activation of TRPV1 by the satiety factor oleoylethanolamide. 2003 J. Biol. Chem. pmid:12761211
Tóth A et al. Arachidonyl dopamine as a ligand for the vanilloid receptor VR1 of the rat. 2003 Life Sci. pmid:12759142
Fowler CJ et al. Acidic nonsteroidal anti-inflammatory drugs inhibit rat brain fatty acid amide hydrolase in a pH-dependent manner. 2003 J Enzyme Inhib Med Chem pmid:12751821
López-Rodríguez ML et al. Design, synthesis and biological evaluation of new endocannabinoid transporter inhibitors. 2003 Eur J Med Chem pmid:12750028
Mimeault M et al. Anti-proliferative and apoptotic effects of anandamide in human prostatic cancer cell lines: implication of epidermal growth factor receptor down-regulation and ceramide production. 2003 Prostate pmid:12746841
Hermann H et al. Dual effect of cannabinoid CB1 receptor stimulation on a vanilloid VR1 receptor-mediated response. 2003 Cell. Mol. Life Sci. pmid:12737320
Clement AB et al. Increased seizure susceptibility and proconvulsant activity of anandamide in mice lacking fatty acid amide hydrolase. 2003 J. Neurosci. pmid:12736361
Ortar G et al. Novel selective and metabolically stable inhibitors of anandamide cellular uptake. 2003 Biochem. Pharmacol. pmid:12732359
Juntunen J et al. Anandamide prodrugs. 1. Water-soluble phosphate esters of arachidonylethanolamide and R-methanandamide. 2003 Eur J Pharm Sci pmid:12729860
Yamaji K et al. Anandamide induces apoptosis in human endothelial cells: its regulation system and clinical implications. 2003 Thromb. Haemost. pmid:12719786
Maccarrone M The blissful state of endothelium. 2003 Thromb. Haemost. pmid:12719771
Marinelli S et al. Presynaptic facilitation of glutamatergic synapses to dopaminergic neurons of the rat substantia nigra by endogenous stimulation of vanilloid receptors. 2003 J. Neurosci. pmid:12716921
Maccarrone M et al. Levodopa treatment reverses endocannabinoid system abnormalities in experimental parkinsonism. 2003 J. Neurochem. pmid:12716433
Jonsson KO et al. AM404 and VDM 11 non-specifically inhibit C6 glioma cell proliferation at concentrations used to block the cellular accumulation of the endocannabinoid anandamide. 2003 Arch. Toxicol. pmid:12698235
Basavarajappa BS et al. Chronic ethanol inhibits the anandamide transport and increases extracellular anandamide levels in cerebellar granule neurons. 2003 Eur. J. Pharmacol. pmid:12679143
Costanzi M et al. Anandamide and memory in CD1 mice: effects of immobilization stress and of prior experience. 2003 Neurobiol Learn Mem pmid:12676519
López-Rodríguez ML et al. Design, synthesis, and biological evaluation of new inhibitors of the endocannabinoid uptake: comparison with effects on fatty acid amidohydrolase. 2003 J. Med. Chem. pmid:12672252
Vandevoorde S et al. Modifications of the ethanolamine head in N-palmitoylethanolamine: synthesis and evaluation of new agents interfering with the metabolism of anandamide. 2003 J. Med. Chem. pmid:12672243
Melck D et al. Cannabimimetic eicosanoids in cancer and inflammation: an update. 2002 Adv. Exp. Med. Biol. pmid:12664614
Derkinderen P et al. Regulation of extracellular signal-regulated kinase by cannabinoids in hippocampus. 2003 J. Neurosci. pmid:12657697
Glaser ST et al. Evidence against the presence of an anandamide transporter. 2003 Proc. Natl. Acad. Sci. U.S.A. pmid:12655057
Holt S and Fowler CJ Anandamide metabolism by fatty acid amide hydrolase in intact C6 glioma cells. Increased sensitivity to inhibition by ibuprofen and flurbiprofen upon reduction of extra- but not intracellular pH. 2003 Naunyn Schmiedebergs Arch. Pharmacol. pmid:12644895
Sarker KP et al. ASK1-p38 MAPK/JNK signaling cascade mediates anandamide-induced PC12 cell death. 2003 J. Neurochem. pmid:12641726
Campanucci VA et al. A novel O2-sensing mechanism in rat glossopharyngeal neurones mediated by a halothane-inhibitable background K+ conductance. 2003 J. Physiol. (Lond.) pmid:12640017
Perrier JF et al. 5-HT1A receptors increase excitability of spinal motoneurons by inhibiting a TASK-1-like K+ current in the adult turtle. 2003 J. Physiol. (Lond.) pmid:12626670
Li J et al. Anandamide-induced depressor effect in spontaneously hypertensive rats: role of the vanilloid receptor. 2003 Hypertension pmid:12623992
Lau AH and Chow SS Effects of cannabinoid receptor agonists on immunologically induced histamine release from rat peritoneal mast cells. 2003 Eur. J. Pharmacol. pmid:12620517
Vandevoorde S et al. N-Morpholino- and N-diethyl-analogues of palmitoylethanolamide increase the sensitivity of transfected human vanilloid receptors to activation by anandamide without affecting fatty acid amidohydrolase activity. 2003 Bioorg. Med. Chem. pmid:12614867
Wisnoskey BJ et al. Activation of vanilloid receptor type I in the endoplasmic reticulum fails to activate store-operated Ca2+ entry. 2003 Biochem. J. pmid:12608892
Randall MD A new endothelial target for cannabinoids. 2003 Mol. Pharmacol. pmid:12606752
Scorticati C et al. The effect of anandamide on prolactin secretion is modulated by estrogen. 2003 Proc. Natl. Acad. Sci. U.S.A. pmid:12578974
Chu CJ et al. N-oleoyldopamine, a novel endogenous capsaicin-like lipid that produces hyperalgesia. 2003 J. Biol. Chem. pmid:12569099
Lo YK et al. Effect of arvanil (N-arachidonoyl-vanillyl-amine), a nonpungent anandamide-capsaicin hybrid, on ion currents in NG108-15 neuronal cells. 2003 Biochem. Pharmacol. pmid:12566085
Jennings EA et al. The actions of anandamide on rat superficial medullary dorsal horn neurons in vitro. 2003 J. Physiol. (Lond.) pmid:12562891
Pearlman RJ et al. Arachidonic acid and anandamide have opposite modulatory actions at the glycine transporter, GLYT1a. 2003 J. Neurochem. pmid:12558979
Ahluwalia J et al. Activation of capsaicin-sensitive primary sensory neurones induces anandamide production and release. 2003 J. Neurochem. pmid:12558978
Yan MS et al. [Cannabinoids, cannabinoid receptor and immune response]. 2000 Sheng Li Ke Xue Jin Zhan pmid:12545719
McVey DC et al. Endocannabinoids induce ileitis in rats via the capsaicin receptor (VR1). 2003 J. Pharmacol. Exp. Ther. pmid:12538826
Sancho R et al. Anandamide inhibits nuclear factor-kappaB activation through a cannabinoid receptor-independent pathway. 2003 Mol. Pharmacol. pmid:12527815
Facchinetti F et al. Cannabinoids ablate release of TNFalpha in rat microglial cells stimulated with lypopolysaccharide. 2003 Glia pmid:12509806
Paria BC et al. Endocannabinoid signaling in synchronizing embryo development and uterine receptivity for implantation. 2002 Chem. Phys. Lipids pmid:12505701
Cravatt BF and Lichtman AH The enzymatic inactivation of the fatty acid amide class of signaling lipids. 2002 Chem. Phys. Lipids pmid:12505696
Schmid HH et al. Cell signaling by endocannabinoids and their congeners: questions of selectivity and other challenges. 2002 Chem. Phys. Lipids pmid:12505695
Wiley JL and Martin BR Cannabinoid pharmacology: implications for additional cannabinoid receptor subtypes. 2002 Chem. Phys. Lipids pmid:12505690
Kunos G et al. The quest for a vascular endothelial cannabinoid receptor. 2002 Chem. Phys. Lipids pmid:12505689
Razdan RK and Mahadevan A Recent advances in the synthesis of endocannabinoid related ligands. 2002 Chem. Phys. Lipids pmid:12505687
Palmer SL et al. Cannabinergic ligands. 2002 Chem. Phys. Lipids pmid:12505686
Németh J et al. Concentration-dependent dual effect of anandamide on sensory neuropeptide release from isolated rat tracheae. 2003 Neurosci. Lett. pmid:12499047
Liu YC and Wu SN Block of erg current by linoleoylamide, a sleep-inducing agent, in pituitary GH3 cells. 2003 Eur. J. Pharmacol. pmid:12498905
Lee LY et al. Functional morphology and physiological properties of bronchopulmonary C-fiber afferents. 2003 Anat Rec A Discov Mol Cell Evol Biol pmid:12494486
Schelegle ES Functional morphology and physiology of slowly adapting pulmonary stretch receptors. 2003 Anat Rec A Discov Mol Cell Evol Biol pmid:12494485
Orliac ML et al. Potentiation of anandamide effects in mesenteric beds isolated from endotoxemic rats. 2003 J. Pharmacol. Exp. Ther. pmid:12490589
Maccarrone M et al. Anandamide activity and degradation are regulated by early postnatal aging and follicle-stimulating hormone in mouse Sertoli cells. 2003 Endocrinology pmid:12488326
Kathuria S et al. Modulation of anxiety through blockade of anandamide hydrolysis. 2003 Nat. Med. pmid:12461523
Schmid PC et al. Anandamide and other N-acylethanolamines in human tumors. 2002 Lipids pmid:12458627
Jerman JC et al. Comparison of effects of anandamide at recombinant and endogenous rat vanilloid receptors. 2002 Br J Anaesth pmid:12453933
Higgs S et al. Cannabinoid influences on palatability: microstructural analysis of sucrose drinking after delta(9)-tetrahydrocannabinol, anandamide, 2-arachidonoyl glycerol and SR141716. 2003 Psychopharmacology (Berl.) pmid:12447606
Szoke E et al. Neonatal anandamide treatment results in prolonged mitochondrial damage in the vanilloid receptor type 1-immunoreactive B-type neurons of the rat trigeminal ganglion. 2002 Neuroscience pmid:12435419
van der Stelt M et al. Acute neuronal injury, excitotoxicity, and the endocannabinoid system. 2002 Oct-Dec Mol. Neurobiol. pmid:12428763
Krylatov AV et al. Endogenous cannabinoids improve myocardial resistance to arrhythmogenic effects of coronary occlusion and reperfusion: a possible mechanism. 2002 Bull. Exp. Biol. Med. pmid:12428277
Gómez R et al. A peripheral mechanism for CB1 cannabinoid receptor-dependent modulation of feeding. 2002 J. Neurosci. pmid:12417686
Geraghty DP and Mazzone SB Respiratory actions of vanilloid receptor agonists in the nucleus of the solitary tract: comparison of resiniferatoxin with non-pungent agents and anandamide. 2002 Br. J. Pharmacol. pmid:12411424
Jia Y et al. Anandamide induces cough in conscious guinea-pigs through VR1 receptors. 2002 Br. J. Pharmacol. pmid:12411414
Del Arco I et al. Attenuation of spontaneous opiate withdrawal in mice by the anandamide transport inhibitor AM404. 2002 Eur. J. Pharmacol. pmid:12409011
Mascolo N et al. The endocannabinoid system and the molecular basis of paralytic ileus in mice. 2002 FASEB J. pmid:12397089